Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Farde

Showing results (51-60 of 207) with videos related to

Pageof 21
Sort By:
Synapse (New York, N.Y.)|February 19, 1999
Changes in striatal D2-receptor density following chronic treatment with amphetamine as assessed with PET in nonhuman primatesN Ginovart, L Farde, C Halldin, et al.
Nuclear Medicine and Biology|November 1, 1995
An HPLC-method for determination of ligand metabolism during PET studies with [11C]metaraminol and [11C]norepinephrineC G Swahn, C Halldin, K Någren, et al.
Synapse (New York, N.Y.)|April 1, 1997
Effect of reserpine-induced depletion of synaptic dopamine on [11C]raclopride binding to D2-dopamine receptors in the monkey brainN Ginovart, L Farde, C Halldin, et al.
International Clinical Psychopharmacology|September 1, 1995
Positron emission tomography studies on D2 dopamine receptor occupancy and plasma antipsychotic drug levels in manS Nyberg, A L Nordström, C Halldin, et al.
The American Journal of Psychiatry|June 9, 1999
Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patientsS Nyberg, B Eriksson, G Oxenstierna, et al.
Psychopharmacology|March 1, 1994
Influence of rate of administration of raclopride on akathisia and prolactin responseG Movin-Osswald, P Karlsson, M Hammarlund-Udenaes, et al.
Psychopharmacology|February 1, 1994
An open clinical and biochemical study of ritanserin in acute patients with schizophreniaF A Wiesel, A L Nordström, L Farde, et al.
Psychopharmacology|June 1, 1997
Central 5-HT2A and D2 dopamine receptor occupancy after sublingual administration of ORG 5222 in healthy menB Andrée, C Halldin, M Vrijmoed-de Vries, et al.
Journal of Neurochemistry|December 1, 1990
Comparison of the in vitro receptor binding properties of N-[3H]methylspiperone and [3H]raclopride to rat and human brain membranesH Hall, I Wedel, C Halldin, et al.
International Clinical Psychopharmacology|August 5, 1998
Implications of brain imaging for the management of schizophreniaS Nyberg, U Nilsson, Y Okubo, et al.
Pageof 21

Showing results (51-60 of 207) with videos related to

Sort By:
Pageof 21
Synapse (New York, N.Y.)|February 19, 1999
Changes in striatal D2-receptor density following chronic treatment with amphetamine as assessed with PET in nonhuman primatesN Ginovart, L Farde, C Halldin, et al.
Nuclear Medicine and Biology|November 1, 1995
An HPLC-method for determination of ligand metabolism during PET studies with [11C]metaraminol and [11C]norepinephrineC G Swahn, C Halldin, K Någren, et al.
Synapse (New York, N.Y.)|April 1, 1997
Effect of reserpine-induced depletion of synaptic dopamine on [11C]raclopride binding to D2-dopamine receptors in the monkey brainN Ginovart, L Farde, C Halldin, et al.
International Clinical Psychopharmacology|September 1, 1995
Positron emission tomography studies on D2 dopamine receptor occupancy and plasma antipsychotic drug levels in manS Nyberg, A L Nordström, C Halldin, et al.
The American Journal of Psychiatry|June 9, 1999
Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patientsS Nyberg, B Eriksson, G Oxenstierna, et al.
Psychopharmacology|March 1, 1994
Influence of rate of administration of raclopride on akathisia and prolactin responseG Movin-Osswald, P Karlsson, M Hammarlund-Udenaes, et al.
Psychopharmacology|February 1, 1994
An open clinical and biochemical study of ritanserin in acute patients with schizophreniaF A Wiesel, A L Nordström, L Farde, et al.
Psychopharmacology|June 1, 1997
Central 5-HT2A and D2 dopamine receptor occupancy after sublingual administration of ORG 5222 in healthy menB Andrée, C Halldin, M Vrijmoed-de Vries, et al.
Journal of Neurochemistry|December 1, 1990
Comparison of the in vitro receptor binding properties of N-[3H]methylspiperone and [3H]raclopride to rat and human brain membranesH Hall, I Wedel, C Halldin, et al.
International Clinical Psychopharmacology|August 5, 1998
Implications of brain imaging for the management of schizophreniaS Nyberg, U Nilsson, Y Okubo, et al.
Pageof 21